Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds
- 1 June 2014
- journal article
- research article
- Published by SAGE Publications in Advances in Wound Care
- Vol. 3 (6) , 419-427
Abstract
Objective: Type 2 diabetes (T2D) is associated with impaired cutaneous wound healing and can result in ulceration, infection, and/or amputation. More than 25 million people in the United States have T2D and are vulnerable to epithelial-related complications. Current therapies are limited in their efficacy. New treatments for full-thickness cutaneous wounds that focus on underlying diabetic pathways are needed. Approach: Topical application of the opioid receptor antagonist naltrexone (NTX) dissolved in cream reverses delayed wound closure in type 1 diabetic rat by the acceleration of reepithelialization and enhancement of angiogenesis and remodeling. NTX blocks the opioid growth factor (OGF)–OGF receptor (OGFr) axis and upregulates DNA synthesis and cell proliferation. To investigate whether NTX is an effective therapy for T2D wound closure, genetically obese mice (db/db) and normal C57Bl/6J mice received full-thickness cutaneous wounds. Wounds (5 mm in diameter) were treated topically three times daily with 10−5 M NTX or sterile saline dissolved in cream and photographed every 2 days. Results: Wounds in db/db mice treated with saline were 11–92% larger than those in normal mice throughout the 2-week observation. Topical NTX therapy in T2D mice reduced the residual wound size by 13–30% between days 8 and 14 relative to diabetic mice receiving saline. Reepithelialization and DNA synthesis, as analyzed by epithelial thickness and BrdU labeling indexes, respectively, were accelerated in NTX-treated wounds. Innovation and Conclusion: These data suggest that the OGF-OGFr axis plays a role in epithelial-related complications of T2D and that blockade of this pathway by NTX may be an effective treatment for wound repair.Keywords
This publication has 23 references indexed in Scilit:
- Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesisExperimental Biology and Medicine, 2013
- Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic miceJournal of Clinical Investigation, 2010
- Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancersAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- The OGF–OGFr Axis Utilizes the p16INK4aand p21WAF1/CIP1Pathways to Restrict Normal Cell ProliferationMolecular Biology of the Cell, 2009
- Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and AngiogenesisStem Cells, 2007
- Topically Applied Naltrexone Restores Corneal Reepithelialization in Diabetic RatsJournal of Ocular Pharmacology and Therapeutics, 2007
- Inflammatory cells during wound repair: the good, the bad and the uglyTrends in Cell Biology, 2005
- Wound healing: an overview of acute, fibrotic and delayed healingFrontiers in Bioscience-Landmark, 2004
- Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: A role for endogenous opioid systems in cancerLife Sciences, 1984
- Increased Brain Size and Cellular Content in Infant Rats Treated with an Opiate AntagonistScience, 1983